Biography

Dr. Gavin Stuart was appointed as the Dean of the Faculty of Medicine, University of British Columbia, in September 2003. Upon being reappointed in September 2009, he also was given the new title of Vice Provost Health for the University.

A native of Manitoba, he attended the University of Western Ontario for his undergraduate medical and postgraduate training in obstetrics and gynecology. This was followed by a Fellowship in Gynecological Oncology at Wayne State University in Detroit.

Dr. Stuart was Director of the Department of Gynecology at the Tom Baker Cancer Centre in Calgary for 10 years. He went on to become Professor and Head of the Department of Oncology at the University of Calgary and Director of the Tom Baker Cancer Centre for 12 years. He was also appointed as Vice-President of the Alberta Cancer Board.

His clinical research interests and publications have been in the area of gynecologic cancer, including population-based screening programs and the conduct of clinical trials as therapeutic interventions in gynecologic cancer.

He is currently the Chair for the Gynecology Site Committee of the National Cancer Institute of Canada (NCIC) Clinical Trials Group. Having been active for many years in the design and implementation of a number of major international intergroup trials in ovarian cancer he is the Chair-elect of the Gynecologic Cancer Intergroup (an international collaboration for clinical trials).

Dr. Stuart has been active in leadership roles in many national and US committees on medical education, health human resource planning and evidence-based guideline development. In his current role, he continues to function as a Gynecological Oncologist and a member of the team at the Vancouver Hospital and BC Cancer Agency, Vancouver.

He enjoys woodworking, running regularly and remains actively involved in alpine ski racing. Dr. Stuart and his wife, Janet, have three young adult children.

Publications

Coldman AJ, Ogilvie G, Krajden M, Van Niekerk D, Ehlen T, Martin R, Stuart G, Peacock S, Smith L, Cook D, Franco E. Colposcopy Utilization Following Primary HPV Screening with Cytology Triage. Oral Presentation, EUROGIN 2013, Florence, Italy, November 2013.

J.N. McAlpine, A.E. Tone, N. Rozenberg, G. Hanely, M. Heywood, G. Stuart, C.B. Gilks, D.G. Huntsman, S.J. Finlayson, D.M. Miller (Canada). Opportunistic Salpingectomy: Impact of Regional Program for Ovarioan Cancer Prevention. Presented at 18th International Meeting of the European Society of Gynaecological Oncology (ESGO), Liverpool, UK, October 19-22, 2013.

Martin R, Ogilvie GS, van Niekerk, Kradjen M, Stuart GCE, Peacock S, Ehlen T, Smith L, Franco EL, Coldman AJ. HPV Primary Screening in a Canadian Population Based Program: The HPV Focal Study, First Round Results. Presented at 2013 North American Primary Care Research Group (NAPCGRG) Annual Meeting, Ottawa, Ontario , November 2013.

Ogilvie G, van Niekerk D, Krajden M, Ceballos K, Ehlen T, Martin R, Smith L, Peacock S, Stuart G, Franco E, Coldman A. Age Specific Round 1 Results of a Cervical Cancer Screening Trial: HPV FOCAL. Oral Presentation, ISSTDR 2013, Vienna, Austria, July 2013.

Smith LW, Ogilvie GS, Cook DA, van Niekerk DJ, Krajden M, Ehlen T, Stuart G, Martin R, Peacock S, Franco EL, Coldman AJ. Incident HPV Infection at 48 Month Exit Screen Among Women in the HPV Focal Trial. Poster Presentation, EUROGIN 2013, Florence, Italy, November 2013.

Grants

CIHR Operating Grant
A randomized controlled evaluation of HPV testing for cervical cancer screening
PI: Andrew J. Coldman Co: Stuart, GCE,

CIHR – Operating Grant
A study of HPV-VLP Vaccine in a cohort of HIV positive girls and women
PI: Money, DM Co: Stuart, GCE

CIHR
Randomized Trial Comparing Radical Hysterectomy and Pelvic Node Dissection vs Simple Hysterectomy and Pelvic Node Dissection in Patients with Low Risk Cervical Cancer Defined as Lesions Measuring Less than 2 cm with Less than 50% Stromal Invasion
PI: Meyer, RM Plante, M Co: Stuart, GCE